Search

everythinglearnresearchcommunity

for

Search:↓

Finasteride improves heart function and repairs damage after heart attack in mice.

Poria cocos polysaccharides and finasteride both help treat chronic nonbacterial prostatitis, but Poria cocos polysaccharides also improve gut health.

The new particle system could be a promising treatment for diseases related to the 5-α reductase enzyme.

A vaccine may prevent benign prostatic hyperplasia (BPH).

The Androgen Receptor could be a target for treating diseases like cancer, but more research is needed to confirm the effectiveness of potential treatments.

We need better ways to test and understand SARMs to make safer and more effective treatments.

Adding a second method to PROTACs could improve cancer treatment.

The study found that androgen receptors in skin cells mainly affect the focal adhesion pathway and control the caveolin-1 gene, with implications for new treatments for related diseases.

Bicalutamide may help treat female pattern hair loss.

The androgen receptor's shape-changing ability helps it function but can lead to cancer treatment resistance.

Natural compounds from Chinese herbs may safely promote hair growth and treat common hair loss.

Heavy metals like arsenic, cadmium, and lead can increase cancer risk and worsen outcomes.

Finasteride effectively treats BPH but requires continuous use to maintain benefits.

Flutamide emulgel with 1% Transcutol P absorbs better through the skin than other mixtures.

Dutasteride is more effective than finasteride for treating BPH without extra safety risks.

Different forms of finasteride dissolve and remain stable differently, affecting capsule quality.

Some patients may experience lasting sexual dysfunction, depression, and other side effects from 5α-reductase inhibitor therapy.

The conclusion is that doctors should be careful when prescribing 5α-reductase inhibitors due to possible serious side effects, and they should discuss these risks with patients.

The document concludes that better training and education are needed for proper cancer screening and criticizes the GMC's inaction as harmful to clinical ethics in the UK.

The document highlights various patents for new compounds with potential treatments for multiple diseases, including cancer, hormonal disorders, and diabetes.

Methylation in specific gene region causes finasteride resistance in some BPH patients.

Finasteride and dutasteride might lower melanoma risk.

Finasteride increases hair count in men with hair loss, but the effect isn't permanent and hair loss returns if treatment stops.

Finasteride reduces urinary issues and surgery need in men with enlarged prostates by over 50%.

Terazosin and finasteride effectively treat BPH, but combining them adds no extra benefit.

Understanding where cancer cells come from helps create better prevention and treatment methods.

Some patients taking finasteride or dutasteride may have ongoing sexual problems and depression even after stopping the medication.

The document concludes that Catalyst software is effective for drug design, identifying potent compounds for various medical conditions.

Low doses of some substances can be beneficial, while high doses can be harmful or toxic.

New treatments for male hypogonadism are effective and should be personalized.